Search Results for "Recall Promus Heart Stent"

12:12 EDT 23rd October 2016 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...


Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

Paclitaxel-eluting balloons reduce late lumen loss in coronary in-stent restenosis

In the prospective, randomized Treatment of In-Stent Restenosis study, use of paclitaxel-eluting balloons to treat bare metal stent restenosis yielded lower rates of late lumen loss at 12 months compa...

Arizona marathon runner receives first dissolvable heart stent

A dissolvable heart

Disappearing act: Nevada Heart and Vascular implants dissolving heart stent

Unlike traditional metal stent, this fully dissolving model leaves no metal behind to restrict natural vessel motion. 

Abbott Laboratories' absorbable heart stent wins FDA nod

Abbott Laboratories has obtained approval from the FDA for its Absorb heart stent, a polymer device that dissolves within thr -More- 

FDA Approves Abbott's Absorbable Heart Stent

The U.S. Food and Drug Administration approved Abbott Laboratories’ absorbable heart stent called Absorb, a device cardiologists say represents a significant advance in treatment of coronary artery ...

Abbott's heart stent wins approval from Canada

Abbott has obtained approval from Health Canada for its Absorb bioresorbable heart stent, a device that dissolves in three ye -More- 

Two deaths spark recall of St. Jude heart devices

(Reuters) - St. Jude Medical Inc on Tuesday said it would recall some of its 400,000 implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe. ...

Abbott’s Absorb bioresorbable heart stent gets FDA approval

Healthcare firm Abbott has received approval from the US Food and Drug Administration (FDA) for its Absorb bioresorbable heart stent to market in the country.

Matching PubMed Articles

Effects of Positive and Negative Mood Induction on the Prefrontal Cortex Activity Measured by Near Infrared Spectroscopy.

The neurophysiological mechanism of positive versus negative emotions is insufficiently understood. In the present study, we examined the effect of event recall tasks on the prefrontal cortex (PFC) ac...

Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?

The natural history and the role of atherosclerotic plaque located behind the stent (PBS) are still poorly understood. We evaluated the serial changes in PBS following bare-metal (BMS) compared to fir...

Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.

In-stent restenosis (ISR) remains an important concern despite the recent advances in the drug-eluting stent (DES) technology. The introduction of drug-eluting balloons (DEB) offers a good solution to...

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†.

Stent thrombosis (ST) is a rare but serious complication following percutaneous coronary intervention. Analysis of thrombus composition from patients undergoing catheter thrombectomy may provide impor...

Impact of Neointimal Calcifications on Acute Stent Performance during the Treatment of In-Stent Restenosis.

Optical coherence tomography (OCT) has become the invasive imaging modality of choice for coronary stent assessment due to its unmatched spatial resolution. Neointimal calcification (NC) is a rare fin...

Search Whole site using Google

Quick Search
Advertisement Advertisement